NIH researchers examine how artemisinin resistant malaria is emerging due to prevalence of poor-quality and fake malaria drugs
Malaria is a mosquito-borne disease causing fever, chills and flu-like illness that can be fatal. Despite an increased focus on malaria, it still claims hundreds of thousands of lives each year, most of them children in Africa.
Fogarty has supported a wide range of efforts to combat malaria, including an international effort to identify and address research priorities, The Multilateral Initiative on Malaria. Fogarty also supports the Ecology and Evolution of Infectious Diseases Initiative, a partnership with the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Environmental Health Sciences that funds malaria-related projects in Kenya, Papua New Guinea and Belize. Most importantly, through its Global Infectious Disease program, Fogarty has supported research training efforts that advance scientific discoveries, while developing local malaria research capacity in places where it's needed most.
The Center's epidemiology division studies malaria transmission patterns, drug resistance and other related topics, modeling malaria's prevalence and impact.
National Institutes of Health - NIH...Turning Discovery into Health ®